Methyl 5-fluoro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate, 95.0%, 10g

5-bromo-4,6-difluoro-2,3-dihydro-1H-indol-2-one, 95.0%, 250mg

(Z)-4,4,5,5-Tetramethyl-2-(prop-1-en-1-yl)-1,3,2-dioxaborolane, 95% mix TBC as stabilizer, 25g

ethyl 8-(2-iodophenyl)-8-oxooctanoate, 97.0%, 2g

9,10-Dihydroacridine, 97%, 250mg

4-Aminopicolinic acid hydrochloride, 95.0%, 5g

N-(2,4-DIMETHOXYBENZYL)-5-FLUOROTHIAZOL-2-AMINE, 90.0%, 250mg

(1H-indol-2-ylmethyl)amine oxalate, 95.0%, 5g

6-Methoxypyridazin-3-amine hydrochloride, 98%, 10g

2-Difluoromethoxyphenylthiourea, 1g

(S)-Methyl 4-(3-methoxyphenyl)-3-methyl-4-oxobutanoate, 95.0%, 250mg

2-Methyl benzo[d]thiazol-6-amine, 96.0%, 10g

1-AMINO-4-((4-((4-CHLORO-6-((2-SULFOPHENYL)AMINO)-1,3,5-TRIAZIN-2-YL)AMINO)-3-SULFOPHENYL)AMINO)-9,10-DIOXO-9,10-DIHYDROANTHRACENE-2-SULFONIC ACID, 94%, 1g